SCHEMBL21149149

SCHEMBL21149149

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5cccc6sc7ccccc7c56)c4)nc(-c4ccc5sc6ccccc6c5c4)n3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.39
PIM3 Q86V86 1/20 0.38
LIMK1 P53667 2/20 0.36
CYP1A2 P05177 1/20 0.35
GPR3 P46089 1/20 0.35
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
MEN1 O00255 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
HPGD P15428 3/20 0.33
KMT2A Q03164 3/20 0.33
F9 P00740 1/20 0.33
MAP3K8 P41279 2/20 0.33
ROCK1 Q13464 1/20 0.33
SLC9A1 P19634 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ATM Q13315 2/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21149136 0.99 PIM3 (0.40) ALOX5PIM3LIMK1CYP1A2GPR3
SCHEMBL21148571 0.99 PIM3 (0.40) ALOX5PIM3LIMK1CYP1A2GPR3
SCHEMBL21148734 0.96 PIM3 (0.40) ALOX5PIM3LIMK1CYP1A2GPR3
SCHEMBL21148602 0.96 PIM3 (0.40) ALOX5PIM3LIMK1CYP1A2GPR3
SCHEMBL21148603 0.96 ALOX5 (0.39) ALOX5PIM3LIMK1CYP1A2GPR3
SCHEMBL21149178 0.96 PIM3 (0.39) ALOX5PIM3LIMK1CYP1A2GPR3
SCHEMBL22760303 0.95 ALOX5 (0.37) ALOX5PIM3LIMK1CYP1A2GPR3
SCHEMBL20982339 0.95 LIMK1 (0.38) ALOX5PIM3LIMK1CYP1A2GPR3
SCHEMBL21148194 0.95 LIMK1 (0.39) ALOX5LIMK1GPR3ADORA2AADORA1
SCHEMBL21148226 0.95 LIMK1 (0.39) ALOX5LIMK1GPR3ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 ALOX5 306/4885PIM3 3857/4885LIMK1 133/4885
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 ALOX5 306/4885PIM3 3857/4885LIMK1 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.